Supreme Antacid Cherry

Description

Supreme Antacid is a calcium-rich formulation designed to provide fast relief from heartburn and acid indigestion. It is presented in a 12 fluid ounce (355 mL) dosage form and is characterized by its Cherry Crème flavor. This product is comparable to the active ingredients found in MYLANTA® Supreme, ensuring effective symptom management.

Uses and Indications

This drug is indicated for the relief of acid indigestion, heartburn, sour stomach, and upset stomach associated with these symptoms.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should instruct patients to shake the product well before use.

For adults and children aged 12 years and older, the recommended dosage is 2 to 4 teaspoonfuls taken two times a day, or as directed by a physician.

For children under 12 years of age, it is advised to consult a doctor for appropriate dosing recommendations.

Contraindications

Use is contraindicated in patients whose symptoms persist for more than two weeks. Prolonged symptoms may indicate an underlying condition that requires further evaluation and management.

Warnings and Precautions

Patients should not exceed a maximum dosage of 18 teaspoonfuls within a 24-hour period. Additionally, the maximum dosage should not be utilized for more than two weeks unless directed and monitored by a healthcare professional.

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center for guidance.

If symptoms persist beyond two weeks, patients are advised to discontinue use and consult a healthcare provider for further evaluation and management.

Side Effects

Patients should be aware of the potential adverse reactions associated with this product. It is crucial to adhere to the recommended dosage, which should not exceed 18 teaspoonfuls in a 24-hour period, and the maximum dosage should not be used for more than 2 weeks without the advice and supervision of a healthcare professional.

In the event that symptoms persist for more than two weeks, patients are advised to discontinue use and consult a doctor.

Before using this product, patients should seek medical advice if they have kidney disease or are on a magnesium-restricted diet, as these conditions may influence the safety and efficacy of the treatment. Additionally, patients currently taking prescription medications should consult a doctor or pharmacist prior to use, as antacids may interact with certain prescription drugs.

These precautions are essential to ensure the safe use of the product and to mitigate the risk of adverse reactions.

Drug Interactions

Antacids may interact with various prescription medications, potentially affecting their absorption and efficacy. It is advisable to monitor the timing of antacid administration in relation to other medications to minimize these interactions. Specifically, antacids should be taken at least 2 hours apart from other drugs to ensure optimal therapeutic effects. Healthcare professionals should consider this timing when prescribing medications that may be affected by antacids.

Packaging & NDC

Below are the non-prescription pack sizes of Supreme Antacid Cherry (calcium carbonate, magnesium hydroxide). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, the recommended dosage is 2 to 4 teaspoonfuls taken twice daily, or as directed by a healthcare provider.

Geriatric Use

Elderly patients should exercise caution when using this medication, particularly those aged 65 and older. It is advisable for geriatric patients to consult a healthcare provider before use if they have a history of kidney disease, as this condition may affect the safety and efficacy of the treatment.

Additionally, elderly patients are encouraged to seek guidance from a doctor or pharmacist prior to using this medication if they are currently taking any prescription drugs. This is important because antacids may interact with certain prescription medications, potentially leading to adverse effects or reduced therapeutic efficacy.

For adults and children aged 12 years and older, the recommended dosage is 2 to 4 teaspoonfuls taken two times a day, or as directed by a healthcare professional. However, for children under 12 years of age, it is essential to consult a doctor for appropriate dosing recommendations.

Monitoring and dose adjustments may be necessary for geriatric patients to ensure safe and effective use of this medication.

Pregnancy

Pregnant patients should be aware that there are no specific safety concerns or dosage modifications associated with the use of this medication during pregnancy. Additionally, no special precautions regarding its use in pregnant individuals have been identified. As such, healthcare professionals should consider the overall clinical context when prescribing this medication to women of childbearing potential. It is advisable to monitor for any potential fetal impacts, although no specific data has been provided in the available information.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In cases of overdosage, it is critical to adhere to the recommended dosage guidelines to prevent adverse effects. The maximum allowable dosage is 18 teaspoonfuls within a 24-hour period. Exceeding this limit may lead to significant health risks. Additionally, the maximum dosage should not be utilized for more than 2 weeks unless specifically directed by a healthcare professional.

Healthcare providers should be vigilant for symptoms that may arise from overdosage, which can vary based on individual patient factors and the extent of the overdose. In the event of suspected overdosage, immediate medical attention is advised.

Management of overdosage should include supportive care and symptomatic treatment as necessary. It is essential for healthcare professionals to monitor the patient closely and provide appropriate interventions based on the clinical presentation. Consultation with a poison control center may also be beneficial in guiding the management of the situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is important to inform patients that if their symptoms persist for more than two weeks, they should discontinue use and consult a doctor.

Patients should be encouraged to discuss their medical history with their healthcare provider, particularly if they have kidney disease or are on a magnesium-restricted diet, as these conditions may affect the safety and efficacy of the medication. Additionally, healthcare providers should recommend that patients consult with a doctor or pharmacist before using this medication if they are currently taking any prescription drugs, as antacids may interact with certain medications.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at a controlled room temperature of 20ºC to 25ºC (68ºF to 77ºF). Freezing is not permitted, as it may compromise the integrity of the product. Care should be taken to ensure that the storage environment maintains these temperature conditions to preserve the product's efficacy and safety.

Additional Clinical Information

The medication is administered orally. For adults and children aged 12 years and older, the recommended dosage is 2 to 4 teaspoonfuls taken twice daily, or as directed by a healthcare professional. For children under 12 years of age, it is advised to consult a doctor for appropriate dosing guidance.

There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Supreme Antacid Cherry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)